These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19762964)

  • 1. Septic shock due to visceral leishmaniasis, probably transmitted from blood transfusion.
    Mpaka MA; Daniil Z; Kyriakou DS; Zakynthinos E
    J Infect Dev Ctries; 2009 Jul; 3(6):479-83. PubMed ID: 19762964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
    Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
    Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis in a patient with active HBV/HDV co-infection.
    Lupia T; Corcione S; Boglione L; Cariti G; De Rosa FG
    J Infect Public Health; 2020 Feb; 13(2):306-308. PubMed ID: 31416795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
    Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN
    BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranoproliferative Glomerulonephritis and Mixed Cryoglobulinemia as a Form of Presentation of Visceral Leishmaniasis.
    Padrón Romero M; Acevedo Ribó MM; Ahijado Hormigos FJ; Díaz Crespo F; Cueto Bravo L; Herraiz Corredor C; Fernández Rojo MÁ; Díaz-Tejeiro Izquierdo R
    Am J Case Rep; 2020 May; 21():e921445. PubMed ID: 32459796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B.
    Tavil B; Seçmeer G; Ozen H; Cengiz AB; Unal S; Gürgey A
    Turk J Pediatr; 2008; 50(1):67-9. PubMed ID: 18365595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure.
    Eichenberger A; Buechi AE; Neumayr A; Hatz C; Rauch A; Huguenot M; Diamantis-Karamitopoulou E; Staehelin C
    BMC Infect Dis; 2017 Jan; 17(1):81. PubMed ID: 28095796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature.
    Tatarelli P; Fornaro G; Del Bono V; Nicolini LA; Raiola AM; Gualandi F; Varaldo R; Di Muccio T; Gramiccia M; Gradoni L; Angelucci E; Viscoli C; Mikulska M
    J Infect Chemother; 2018 Dec; 24(12):990-994. PubMed ID: 30098915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of pediatric visceral leishmaniasis-related hemophagocytic lymphohistiocytosis diagnosed by mNGS.
    Guo F; Kang L; Xu M
    Int J Infect Dis; 2020 Aug; 97():27-29. PubMed ID: 32425641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
    Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
    Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic considerations about visceral leishmaniasis. Two case report.
    Pasticci MB; Papili R; Menichetti F; Ballanti S; Ottaviani L; Tabilio A; Stagni G
    Infez Med; 2002 Sep; 10(3):176-8. PubMed ID: 12704269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
    Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
    BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Visceral Leishmaniasis Caused by Leishmania infantum in Northern Cyprus.
    Sayili A; Ozkan AT; Schallig HD
    Am J Trop Med Hyg; 2016 Dec; 95(6):1386-1388. PubMed ID: 27698271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A patient with visceral leishmaniasis and acute renal failure in necrotizing glomerulonephritis].
    Chaigne V; Knefati Y; Lafarge R; Bronner J; Mc Gregor B; Fouque D; Sabatier JC
    Nephrologie; 2004; 25(5):179-83. PubMed ID: 15455792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol.
    Khodabandeh M; Rostami A; Borhani K; Gamble HR; Mohammadi M
    Parasitol Int; 2019 Oct; 72():101934. PubMed ID: 31129197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.
    Malik AN; John L; Bruceson AD; Lockwood DN
    Emerg Infect Dis; 2006 Aug; 12(8):1257-9. PubMed ID: 16965709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visceral leishmaniasis in patient with HIV infection].
    Olea P; Pinilla J
    Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
    Tapisiz A; Belet N; Ciftçi E; Ince E; Dogru U
    J Trop Pediatr; 2007 Oct; 53(5):359-61. PubMed ID: 17626064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral Leishmaniasis in a Liver Transplant Patient: A Case Report.
    de Sousa Arantes Ferreira G; Conde Watanabe AL; de Carvalho Trevizoli N; Felippe Jorge FM; de Fatima Couto C; de Oliveira Nunes Cajá G; Viana de Lima L; Liduario Raupp DR
    Transplant Proc; 2020 Jun; 52(5):1417-1421. PubMed ID: 32192740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hunt for an elusive source of pyrexia in a foreign worker.
    Lew JW; Koh CK; Selvan VS; Shen E
    Singapore Med J; 2007 Apr; 48(4):e111-3. PubMed ID: 17384865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.